# Trifluent Pharma, LLC – FDA Inspection, Jun 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/trifluent-pharma-llc/d5f40a12-b2a8-4235-961c-e9f80e59b2c6
Source feed: FDA_Inspections

> FDA inspection 1321580 of Trifluent Pharma, LLC, June 11, 2026. 2 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321580
- Company Name: Trifluent Pharma, LLC
- Inspection Date: 2026-06-11
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)
- [FDA Associated Person](https://www.keypedia.com/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)

Company: https://www.keypedia.com/companies/trifluent-pharma-llc/57969e2d-86a8-4a86-85b3-f9c3a740e3fc

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9